Impact of a Clinical Decision Support System on the Management of Patients with Hypercholesterolemia in the Primary Healthcare Setting
Abstract
Introduction and objectives: The Optimcare study objective was to assess the impact on effectiveness and costs of a practice guideline implemented through a clinical decision support system (CDSS) for the management of patients with hypercholesterolemia in the primary healthcare setting. Study design and perspective: The study design was a prospective, naturalistic, single-center (Vila Olimpica Primary Health Care Center, Barcelona, Spain), before-and-after design. Two periods were compared: (i) one year before (PRE) the implementation of the CDSS; and (ii) 1 year after (POS) the implementation of the CDSS. The recruitment period started in October 1999 (first patient, first visit) and ended 1 year later (last patient, last visit). The effectiveness was defined by the achievement of the treatment goals in PRE and POS periods. Costs of treatments, visits, and laboratory assessments were estimated from the social perspective (year of costing 2002). Methods: The CDSS implemented algorithms agreed by the participating physicians based on national clinical guidelines, with therapeutic recommendations directed to achieve low-density lipoprotein (LDL) objectives in a cost-effective manner. Patients: A total of 500 patients with hypercholesterolemia were randomly selected from the Primary Health Care center database. Main outcome measures and results: After implementing the CDSS, the proportion of patients meeting the treatment goals increased by 11.9% (95% CI 5.9, 17.8), the median LDL values decreased by 10 mg/dL (95% CI -14, -6), the proportion of patients treated with drugs decreased by 14.6% (95% CI -19.4, -9.7), and the mean total costs per patient decreased by _78.4 (95% CI -94.7, -62.1). Therapeutic decisions agreed with the CDSS recommendations in 87.4% of the POS visits. Discussion and conclusions: Despite some limitations in the design, the results of the present study strongly suggest that it is possible to optimize the efficiency of the management of hypercholesterolemia in standard practice by the implementation of a CDSS. After this implementation, not only were the effectiveness outcomes improved, but also a yearly mean reduction of _78.4 in the costs of management of patients with hypercholesterolemia was observed. This cost reduction, which was mainly due to a decrease in the number of patients treated with drugs, reverted to the spontaneous trend of a marked increase in the use of statins that was reported in Spain and other European countries during the study period.Download Info
If you experience problems downloading a file, check if you have the proper application to view it first. In case of further problems read the IDEAS help page. Note that these files are not on the IDEAS site. Please be patient as the files may be large.As the access to this document is restricted, you may want to look for a different version under "Related research" (further below) or search for a different version of it.
Bibliographic Info
Article provided by Wolters Kluwer Health | Adis in its journal Disease Management & Health Outcomes.
Volume (Year): 13 (2005)
Issue (Month): 1 ()
Pages: 65-72
Download reference. The following formats are available: HTML
(with abstract),
plain text
(with abstract),
BibTeX,
RIS (EndNote, RefMan, ProCite),
ReDIF
Handle: RePEc:wkh:dmhout:v:13:y:2005:i:1:p:65-72
Contact details of provider:
Web page: http://diseasemanagement.adisonline.com/
For corrections or technical questions regarding this item, or to correct its listing, contact: (Dave Dustin).
Related research
Keywords: Cost-analysis; Hypercholesterolaemia; Practice-guideline;Find related papers by JEL classification:
- C - Mathematical and Quantitative Methods
- D - Microeconomics
- I - Health, Education, and Welfare
- Z - Other Special Topics
- I1 - Health, Education, and Welfare - - Health
- I19 - Health, Education, and Welfare - - Health - - - Other
- I18 - Health, Education, and Welfare - - Health - - - Government Policy; Regulation; Public Health
- I11 - Health, Education, and Welfare - - Health - - - Analysis of Health Care Markets
References
No references listed on IDEASYou can help add them by filling out this form.
Citations
Lists
This item is not listed on Wikipedia, on a reading list or among the top items on IDEAS.Statistics
Access and download statisticsCorrections
When requesting a correction, please mention this item's handle: RePEc:wkh:dmhout:v:13:y:2005:i:1:p:65-72For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Dave Dustin).
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If references are entirely missing, you can add them using this form.
If the full references list an item that is present in RePEc, but the system did not link to it, you can help with this form.
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your profile, as there may be some citations waiting for confirmation.
Please note that corrections may take a couple of weeks to filter through the various RePEc services.

